News for DexCom, Inc. (DXCM)

Shares of DexCom Inc (DXCM) surged 5.21% in mid-day trading on Apr 24. The stock reached an intraday high of $70.55, before settling at $70.35, up from its

SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board membe

Here are four promising growth stocks that can help increase the value of your investment portfolio.

PR NewswireNEW YORK, April 22, 2025 NEW YORK, April 22, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether c

Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASD

SAN DIEGO, April 16, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board membe

The stock market is experiencing significant downward pressure on Wednesday, April 16, 2025, as investors react to new export restrictions affecting tech

BOSTON, April 15, 2025 /PRNewswire/ -- Below is the March 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE:ASG).

BTIG has revised its price target for DexCom (DXCM), reducing it to $107 from the previous $120, while maintaining a Buy rating on the stock. This adjustment co

DXCM secures FDA clearance for its G7 15-Day CGM, the longest-lasting and most accurate wearable, enhancing user convenience and expanding diabetes care access.

U.S. stock markets experienced significant declines by midday as initial optimism from a temporary suspension of some tariffs was overshadowed by continued trad

Amazon CEO Andy Jassy says the retailer’s third-party sellers may “pass costs on” related to President Donald Trump’s tariffs to customers.

Key Highlights for DexCom Inc. Investors: DexCom anticipates sustained growth driven by its innovative product lineup and broader market access. The aver

DexCom gains significant momentum as FDA approves its innovative G7 glucose monitoring system. Analysts project a promising upside, with target prices s

For those who can afford it without blowing their budget, it's actually a great idea to pick up shares of top companies on the dip during a correction. With that in mind, here are two excellent growth-oriented companies to buy in the ongoing market meltdown: tech giant Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) and medical device maker DexCom (NASDAQ: DXCM).

U.S. stocks were lower, with the Dow Jones index dipping over 800 points on Thursday. Shares of PriceSmart, Inc. PSMT rose sharply during Thursday's session fo...

[url="]DexCom, Inc.[/url] (NASDAQ:DXCM) today announced that it plans to release its first quarter 2025 financial results after market close on Thursday, May 1

Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A copy of the same can be downloaded here. Select Growth primarily targets U.S. companies that are leading the way in crucial areas of positive structural transformation within the economy. The fund returned 8.8% (net) in the fourth […]

BURNABY, British Columbia — As of today, the Government of Saskatchewan’s expanded public coverage for continuous glucose monitoring (CGM) systems comes into effec…